PharmaCyte Biotech Inc (PMCB)

[concordia]

To say the funding is not an issue is foolish. The company is spending approx. 2 million $ a qtr. without any ongoing clinical trials. For a year long trial that will probably cost 8-10 million the company will need to raise 16-18 million $ over the next 12 months. At .055 a share that would require them to sell about 300,000,000 shares just to fund their activity over a 12 month period. Even if they could use their ATM the market for that amount of shares is more then this company trades in an entire year. If the funding question is not answered in a clear fashion next Thursday then the call will be totally useless.